SUPA71 COMPANY LIMITED

SUPA71 COMPANY LIMITED specializes in scientific and technical support for infectious disease surveillance and research, delivering non-personal services that enable evidence-based public health decision-making in complex operational environments. Their core capabilities include epidemiological data collection and analysis, laboratory surveillance system design, field research coordination, and technical reporting for biosecurity applications. The firm demonstrates deep expertise in field-deployable diagnostic support frameworks, pathogen tracking methodologies, and cross-border health intelligence integration, particularly in Southeast Asian contexts. Their differentiation lies in culturally adaptive implementation of surveillance protocols and seamless coordination with local health authorities under limited infrastructure conditions, ensuring actionable intelligence for defense and public health stakeholders. The contractor has demonstrated direct experience supporting the Department of Defense in mission-critical health security initiatives, specifically in the domain of infectious disease monitoring in the Greater Mekong Subregion. Their work aligns with DoD’s Global Health Engagement and Defense Threat Reduction objectives, providing non-personal scientific support that enhances situational awareness for biological threat detection and response planning. Their primary industry focus is Research and Development in the Physical, Engineering, and Life Sciences, excluding nanotechnology and biotechnology, with practical application in public health surveillance systems, field epidemiology, and biosecurity research. They position themselves as a niche provider of operational science services tailored to defense and international health security programs, particularly in resource-constrained environments. SUPA71 COMPANY LIMITED is a Woman-Owned Business with a 2L entity structure and a geographic presence based in Bangkok, Thailand. This positioning enables regional access to Southeast Asian health systems while maintaining a compliant U.S. government contracting footprint. Their certification enhances eligibility for set-aside programs and signals commitment to diversity in federal contracting ecosystems.